DuPont, Caribou partner on CRISPR-Cas technologies
DuPont and Caribou Biosciences, a developer of CRISPR-Cas technologies for genome editing, have announced a strategic alliance. IFT Daily News
DuPont and Caribou Biosciences, a developer of CRISPR-Cas technologies for genome editing, have announced a strategic alliance. IFT Daily News